AUDACIOUS Opens Medical Cannabis Clinic in Southeast Asia

LAS VEGAS – Just as the dynamic Thai medical cannabis market begins to blossom, AUDACIOUS and Thai-based partner Golden Triangle Health have partnered to open the first Herbidus Medical Center in Bangkok, which is also the first medical cannabis clinic in Southeast Asia supported by a U.S. Multi-State Operator (MSO).

Herbidus is among the first clinics in Asia that can prescribe cannabis for medical treatments in compliance with the law. It uses medicine approved by the Government Pharmaceutical Organization and is staffed by doctors that follow global standards for use of cannabis in patient treatment.

“Interest in medical cannabis is expanding rapidly in Thailand,” said Terry Booth, Chief Executive Officer at AUDACIOUS. “With the opening of the Herbidus Medical Center, we are looking forward to bringing AUDACIOUS’ cannabis expertise and seasoned corporate leadership to the Thai cannabis market. This is one of several initiatives that we are embarking on with Golden Triangle Health, which along with its parent company enjoys robust distribution channels across Thailand, as well as nimble and powerful white label capabilities for cannabis product manufacturing.”

Mr. Booth continued, “GTH will also receive support from our Chief Science Officer, Dr. Jason Dyck, and will be able to utilize his knowledge and experience. This provides Herbidus with access to one of the global leaders in medical cannabis science, resulting in Herbidus patients receiving the highest standards of care in the industry. This will leverage the years of research we have performed in Canada and other countries, including Dr. Dyck’s studies on one of the world’s largest databases of medical cannabis users to identify the primary reasons for medical cannabis authorization and the health outcomes of these patients.”

As Thailand begins to more aggressively expand opportunities for legal cannabis businesses, AUDACIOUS and Golden Triangle Health are poised to serve the nation of 70 million people with cannabis services and products grounded in years of successful and professional cannabis pursuits in North America.

Itself a spin off from Thai public company NR Instant Produce PCL with market cap close to $400M, GTH is well positioned to grow rapidly in the nascent Thai market. Following a soft launch, Herbidus has already seen close to 800 patients, showing the pent-up demand in Thailand for medical cannabis related services. Dr. Jason Dyck, CSO at AUDACIOUS, commented, “Leveraging the knowledge gained from years of studying one of the world’s largest databases of medical cannabis users, we have made significant advances in understanding the medical conditions that patients are seeking cannabis treatment for as well as studying the health outcomes of these patients. The results of these studies will now become an integral part of the knowledge base of the practitioners at our Herbidus clinics to help our patients.”

Golden Triangle co-founder Tom Kruesopon said, “Golden Triangle Health already has strong brand equity in Thailand and across Asia. Our partnership with AUDACIOUS to open Herbidus helps propel us even further,” “We believe that together, we can be one of the most important players in the Asian cannabis market, following our joint launch in the Asian CBD market earlier this year.”

Added AUDACIOUS Chief Operating Officer Duke Fu: “We believe the nascent cannabis market in Asia offers thrilling new and massive addressable market for AUDACIOUS. Given Golden Triangle Health’s extensive and positive track record with distribution, cannabis and hemp manufacturing and healthcare in Thailand, we know this partnership is ideal for showcasing the true medical and economic benefits of cannabis.”

Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this news release.

FORWARD-LOOKING STATEMENTS:
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute “forward-looking information” within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this news release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except as required by applicable securities laws.

(This information is primarily sourced from Australis Capital Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).